{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:54:59Z","timestamp":1783137299292,"version":"3.54.6"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:00:00Z","timestamp":1646438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:00:00Z","timestamp":1646438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-022-06458-8","type":"journal-article","created":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T17:02:34Z","timestamp":1646499754000},"page":"1221-1234","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Axillary lymph node dissection vs. sentinel node biopsy for early-stage clinically node-negative breast cancer: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"306","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5564-0406","authenticated-orcid":false,"given":"Stamatios","family":"Petousis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Christidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrysoula","family":"Margioula-Siarkou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Liberis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Vavoulidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Margioula-Siarkou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Vatopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexios","family":"Papanikolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Mavromatidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Dinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,5]]},"reference":[{"key":"6458_CR1","doi-asserted-by":"crossref","unstructured":"Giuliano AE, Kirgan DM, Guenther JM, Morton DL (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. In: Annals of surgery. Lippincott Williams and Wilkins, pp 391\u2013401","DOI":"10.1097\/00000658-199409000-00015"},{"issue":"6","key":"6458_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0960-7404(93)90064-6","volume":"2","author":"DN Krag","year":"1993","unstructured":"Krag DN, Weaver DL, Alex JC, Fairbank JT (1993) Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2(6):335\u2013340","journal-title":"Surg Oncol"},{"issue":"4","key":"6458_CR3","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/sj.bjc.6601150","volume":"89","author":"F Peintinger","year":"2003","unstructured":"Peintinger F, Reitsamer R, Stranzl H, Ralph G (2003) Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br J Cancer 89(4):648\u2013652","journal-title":"Br J Cancer"},{"key":"6458_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.amjsurg.2003.10.028","volume":"188","author":"MC Kelley","year":"2004","unstructured":"Kelley MC, Hansen N, McMasters KM (2004) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Am J Surg 188:49\u201361","journal-title":"Am J Surg"},{"issue":"2","key":"6458_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10549-018-4733-y","volume":"170","author":"P Roy","year":"2018","unstructured":"Roy P, Leizorovicz A, Villet R, Mercier C, Bobin JY (2018) Systematic versus sentinel-lymph-node-driven axillary-lymph-node dissection in clinically node-negative patients with operable breast cancer. Results of the GF-GS01 randomized trial. Breast Cancer Res Treat 170(2):303\u2013312","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"6458_CR6","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1245\/s10434-016-5177-4","volume":"23","author":"G Canavese","year":"2016","unstructured":"Canavese G, Bruzzi P, Catturich A, Tomei D, Carli F, Garrone E et al (2016) Sentinel lymph node biopsy versus axillary dissection in node-negative early-stage breast cancer: 15-year follow-up update of a randomized clinical trial. Ann Surg Oncol 23(8):2494\u20132500","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"6458_CR7","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/SLA.0b013e3181c0e92a","volume":"251","author":"U Veronesi","year":"2010","unstructured":"Veronesi U, Viale G, Paganelli G, Zurrida S, Luini A, Galimberti V et al (2010) Sentinel lymph node biopsy in breast cancer: ten-year results: of a randomized controlled study. Ann Surg 251(4):595\u2013600","journal-title":"Ann Surg"},{"issue":"2","key":"6458_CR8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/SLA.0b013e31812e6a73","volume":"247","author":"G Zavagno","year":"2008","unstructured":"Zavagno G, De Salvo GL, Scalco G, Bozza F, Barutta L, Del Bianco P et al (2008) A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the sentinella\/GIVOM trial. Ann Surg 247(2):207\u2013213","journal-title":"Ann Surg"},{"key":"6458_CR9","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:332\u2013336","journal-title":"BMJ"},{"key":"6458_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"issue":"4","key":"6458_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J et al (2011) GRADE guidelines: 1. Introduction\u2014GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64(4):383\u2013394","journal-title":"J Clin Epidemiol"},{"key":"6458_CR12","unstructured":"Hazard Ratio Calculator\u2014Calculate Hazard Ratio, HR Confidence Intervals & p-value [Internet]. [cited 2020 Jun 22]. Available from: https:\/\/www.gigacalculator.com\/calculators\/hazard-ratio-calculator.php"},{"key":"6458_CR13","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ [Internet]. 2003 Sep 6 [cited 2018 Aug 27];327(7414):557\u201360. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12958120","DOI":"10.1136\/bmj.327.7414.557"},{"issue":"6","key":"6458_CR14","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1056\/NEJMoa012782","volume":"349","author":"U Veronesi","year":"2003","unstructured":"Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349(6):546\u2013553","journal-title":"N Engl J Med"},{"issue":"19","key":"6458_CR15","doi-asserted-by":"publisher","first-page":"4312","DOI":"10.1200\/JCO.2005.03.228","volume":"23","author":"AD Purushotham","year":"2005","unstructured":"Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP et al (2005) Morbidity after sentinel lymph node biopsy in primary breast cancer: Results from a randomized controlled trial. J Clin Oncol 23(19):4312\u20134321","journal-title":"J Clin Oncol"},{"issue":"1","key":"6458_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.sla.0000167759.15670.14","volume":"242","author":"G Martelli","year":"2005","unstructured":"Martelli G, Boracchi P, De Palo M, Pilotti S, Oriana S, Zucali R et al (2005) A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: Results after 5 years of follow-up. Ann Surg 242(1):1\u20136","journal-title":"Ann Surg"},{"key":"6458_CR17","unstructured":"Journals O. JNCI Journal of the National Cancer Institute Way to Better DNA. Ann Intern Med [Internet]. 2008 [cited 2020 Jun 23];37(5):1\u20139. Available from: www.chem-tox-ecotox.org\/ScientificReviews"},{"issue":"12","key":"6458_CR18","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S1470-2045(06)70947-0","volume":"7","author":"U Veronesi","year":"2006","unstructured":"Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V et al (2006) Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 7(12):983\u2013990","journal-title":"Lancet Oncol"},{"issue":"3","key":"6458_CR19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10549-005-9025-7","volume":"95","author":"A Fleissig","year":"2006","unstructured":"Fleissig A, Fallowfield LJ, Langridge CI, Johnson L, Newcombe RG, Dixon JM et al (2006) Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 95(3):279\u2013293","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"6458_CR20","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.ejso.2008.06.013","volume":"35","author":"G Helms","year":"2009","unstructured":"Helms G, K\u00fchn T, Moser L, Remmel E, Kreienberg R (2009) Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection\u2014data from a prospective randomised trial. Eur J Surg Oncol 35(7):696\u2013701","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"6458_CR21","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1245\/s10434-008-0229-z","volume":"16","author":"G Gill","year":"2009","unstructured":"Gill G (2009) Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial. Ann Surg Oncol 16(2):266\u2013275","journal-title":"Ann Surg Oncol"},{"key":"6458_CR22","unstructured":"Patienten S, Therapie N (2020) PAKT Inhibitor May Promote Better Responses to Abiraterone in mCRPC. onclive [Internet]. [cited 2020 Jun 23];7(6):1\u20137. Available from: https:\/\/www.elespanol.com\/ciencia\/salud\/20180925\/espanoles-saben-funcionara-ultimo-cancer\/340716490_0.html"},{"issue":"25","key":"6458_CR23","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.1200\/JCO.2010.28.2491","volume":"28","author":"SR Land","year":"2010","unstructured":"Land SR, Kopec JA, Julian TB, Brown AM, Anderson SJ, Krag DN et al (2010) Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32. J Clin Oncol 28(25):3929\u20133936","journal-title":"J Clin Oncol"},{"issue":"10","key":"6458_CR24","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP et al (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: Overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11(10):927\u2013933","journal-title":"Lancet Oncol"},{"issue":"2","key":"6458_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/jso.21535","volume":"102","author":"T Ashikaga","year":"2010","unstructured":"Ashikaga T, Krag DN, Land SR, Julian TB, Anderson SJ, Brown AM et al (2010) Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol 102(2):111\u2013118","journal-title":"J Surg Oncol"},{"issue":"1","key":"6458_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1245\/s10434-010-1217-7","volume":"18","author":"G Martelli","year":"2011","unstructured":"Martelli G, Miceli R, Daidone MG, Vetrella G, Cerrotta AM, Piromalli D et al (2011) Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-up. Ann Surg Oncol 18(1):125\u2013133","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"6458_CR27","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA - J Am Med Assoc 305(6):569\u2013575","journal-title":"JAMA - J Am Med Assoc"},{"key":"6458_CR28","doi-asserted-by":"crossref","unstructured":"Goyal A, Newcombe RG, Chhabra A, Mansel RE, ALMANAC Trialists Group (2006) Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase. Breast Cancer Res Treat [Internet]. 2006 Sep [cited 2020 Jun 23];99(2):203\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16541308","DOI":"10.1007\/s10549-006-9192-1"},{"issue":"6","key":"6458_CR29","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1097\/SLA.0b013e31827660a8","volume":"256","author":"G Martelli","year":"2012","unstructured":"Martelli G, Boracchi P, Ardoino I, Lozza L, Bohm S, Vetrella G et al (2012) Axillary dissection versus no axillary dissection in older patients with T1N0 breast cancer: 15-year results of a randomized controlled trial. Ann Surg 256(6):920\u2013924","journal-title":"Ann Surg"},{"issue":"4","key":"6458_CR30","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","volume":"14","author":"V Galimberti","year":"2013","unstructured":"Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P et al (2013) Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23\u201301): a phase 3 randomised controlled trial. Lancet Oncol 14(4):297\u2013305","journal-title":"Lancet Oncol"},{"issue":"1","key":"6458_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1245\/s10434-014-3928-7","volume":"22","author":"N Wetzig","year":"2015","unstructured":"Wetzig N, Gill PG, Zannino D, Stockler MR, Gebski V, Ung O et al (2015) Sentinel lymph node based management or routine axillary clearance? Three-year outcomes of the RACS sentinel node biopsy versus axillary clearance (SNAC) 1 trial. Ann Surg Oncol 22(1):17\u201323","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"6458_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-15-1","volume":"15","author":"LM Van Roozendaal","year":"2015","unstructured":"Van Roozendaal LM, de Wilt JHW, Van Dalen T, Van der Hage JA, Strobbe LJA, Boersma LJ et al (2015) The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013\u201307). BMC Cancer 15(1):1\u20138","journal-title":"BMC Cancer"},{"key":"6458_CR33","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jamcollsurg.2016.04.048","volume":"223","author":"AE Cyr","year":"2016","unstructured":"Cyr AE, Tucker N, Ademuyiwa F, Margenthaler JA, Aft RL, Eberlein TJ et al (2016) Successful completion of the pilot phase of a randomized controlled trial comparing sentinel lymph node biopsy to no further axillary staging in patients with clinical T1\u2013T2 N0 breast cancer and normal axillary ultrasound. J Am Coll Surg 223:399\u2013407","journal-title":"J Am Coll Surg"},{"issue":"30","key":"6458_CR34","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.breast.2016.06.016","volume":"1","author":"C Tinterri","year":"2016","unstructured":"Tinterri C, Canavese G, Bruzzi P, Dozin B (2016) SINODAR ONE, an ongoing randomized clinical trial to assess the role of axillary surgery in breast cancer patients with one or two macrometastatic sentinel nodes. Breast 1(30):197\u2013200","journal-title":"Breast"},{"issue":"3","key":"6458_CR35","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"AE Giuliano","year":"2016","unstructured":"Giuliano AE, Ballman K, McCall L, Beitsch P, Whitworth PW, Blumencranz P et al (2016) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American college of surgeons oncology group (Alliance) ACOSOG Z0011 randomized trial. Ann Surg 264(3):413\u2013419","journal-title":"Ann Surg"},{"issue":"4","key":"6458_CR36","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1245\/s10434-016-5669-2","volume":"24","author":"N Wetzig","year":"2017","unstructured":"Wetzig N, Gill PG, Espinoza D, Mister R, Stockler MR, Gebski VJ et al (2017) Sentinel-lymph-node-based management or routine axillary clearance? Five-year outcomes of the RACS sentinel node biopsy versus axillary clearance (SNAC) 1 trial: assessment and incidence of true lymphedema. Ann Surg Oncol 24(4):1064\u20131070","journal-title":"Ann Surg Oncol"},{"key":"6458_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3361-y","author":"J de Boniface","year":"2017","unstructured":"de Boniface J, Frisell J, Andersson Y, Bergkvist L, Ahlgren J, Ryd\u00e9n L et al (2017) Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-017-3361-y","journal-title":"BMC Cancer"},{"issue":"10","key":"6458_CR38","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR et al (2017) Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA - J Am Med Assoc 318(10):918\u2013926","journal-title":"JAMA - J Am Med Assoc"},{"issue":"10","key":"6458_CR39","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","volume":"19","author":"V Galimberti","year":"2018","unstructured":"Galimberti V, Cole BF, Viale G, Veronesi P, Vicini E, Intra M et al (2018) Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23\u201301): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncol 19(10):1385\u20131393","journal-title":"Lancet Oncol"},{"issue":"1","key":"6458_CR40","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12957-020-01886-9","volume":"18","author":"S Liu","year":"2020","unstructured":"Liu S, Wang N, Gao P, Liu P, Yang H, Xie F et al (2020) Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema. World J Surg Oncol 18(1):118","journal-title":"World J Surg Oncol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-022-06458-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-022-06458-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-022-06458-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T09:08:59Z","timestamp":1663060139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-022-06458-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,5]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["6458"],"URL":"https:\/\/doi.org\/10.1007\/s00404-022-06458-8","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,5]]},"assertion":[{"value":"31 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors disclose no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No human participants having being undergone experimental practice, humans have just contributed questionnaire and epidemiological data were correlated.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"No informed consent needed because of kind of study (systematic review and meta-analysis).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}